FILGOTINIB (Jyseleca®)

Clinical Indication

Moderate to severe arthritis


In line with NICE TA676


Date of classification

May 2021


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.